Literature DB >> 22217429

Diet in phenylketonuria: a snapshot of special dietary costs and reimbursement systems in 10 international centers.

A Belanger-Quintana1, K Dokoupil, H Gokmen-Ozel, A M Lammardo, A MacDonald, K Motzfeldt, M Nowacka, M Robert, M van Rijn, K Ahring.   

Abstract

BACKGROUND AND AIMS: To gather exploratory data on the costs and reimbursement of special dietary foods used in the management of phenylketonuria (PKU) from ten international specialist PKU centers.
METHODS: Experts from each center provided data on retail costs of the three most frequently used phenylalanine-free protein substitutes and low-protein foods at their center; reimbursement of protein substitutes and low-protein foods; and state monetary benefits provided to PKU patients.
RESULTS: The mean annual cost of protein substitutes across 4 age groups (2 y, 8 y, 15 y and adults) ranged from €4273 to €21,590 per patient. The cost of low-protein products also differed; the mean cost of low-protein bread varied from €0.04 to €1.60 per 100 kcal. All protein substitutes were either fully reimbursed or covered by health insurance. However, reimbursement for low-protein products varied and state benefits differed between centers.
CONCLUSIONS: The variation in the cost and reimbursement of diet therapy and the level of additional state benefits for PKU patients demonstrates the large difference in expenditure on and access to PKU dietary products. This highlights the inequality between healthcare systems and access to special dietary products for people with PKU, ultimately leading to patients in some countries receiving better care than others. Copyright Â
© 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22217429     DOI: 10.1016/j.ymgme.2011.12.004

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  10 in total

Review 1.  Current situation and prospects of newborn screening and treatment for Phenylketonuria in China - compared with the current situation in the United States, UK and Japan.

Authors:  Lin Mei; Peipei Song; Norihiro Kokudo; Lingzhong Xu; Wei Tang
Journal:  Intractable Rare Dis Res       Date:  2013-11

2.  Dietary patterns, cost and compliance with low-protein diet of phenylketonuria and other inherited metabolic diseases.

Authors:  T Mlčoch; R Puda; P Ješina; M Lhotáková; Š Štěrbová; T Doležal
Journal:  Eur J Clin Nutr       Date:  2017-06-28       Impact factor: 4.016

3.  Phenylketonuria patients' and their parents' knowledge and attitudes to the daily diet - multi-centre study.

Authors:  Ewa Witalis; Bozena Mikoluc; Radoslaw Motkowski; Jolanta Sawicka-Powierza; Agnieszka Chrobot; Bozena Didycz; Agata Lange; Renata Mozrzymas; Andrzej Milanowski; Maria Nowacka; Mariola Piotrowska-Depta; Hanna Romanowska; Ewa Starostecka; Jolanta Wierzba; Magdalena Skorniewska; Barbara Iwona Wojcicka-Bartlomiejczyk; Maria Gizewska; Halina Car
Journal:  Nutr Metab (Lond)       Date:  2017-08-17       Impact factor: 4.169

4.  Household financial burden of phenylketonuria and its impact on treatment in China: a cross-sectional study.

Authors:  Lin Wang; Hui Zou; Fang Ye; Kundi Wang; Xiaowen Li; Zhihua Chen; Jie Chen; Bingjuan Han; Weimin Yu; Chun He; Ming Shen
Journal:  J Inherit Metab Dis       Date:  2016-11-10       Impact factor: 4.982

5.  Prescribing issues experienced by people living with phenylketonuria in the UK.

Authors:  Suzanne Ford; Mike O'Driscoll; Anita MacDonald
Journal:  Mol Genet Metab Rep       Date:  2019-10-25

6.  Special Low Protein Foods Prescribed in England for PKU Patients: An Analysis of Prescribing Patterns and Cost.

Authors:  Georgina Wood; Alex Pinto; Sharon Evans; Anne Daly; Sandra Adams; Susie Costelloe; Joanna Gribben; Charlotte Ellerton; Anita Emm; Sarah Firman; Suzanne Ford; Moira French; Lisa Gaff; Emily Giuliano; Melanie Hill; Inderdip Hunjan; Camille Newby; Allison Mackenzie; Rachel Pereira; Celine Prescott; Louise Robertson; Heidi Seabert; Rachel Skeath; Simon Tapley; Allyson Terry; Alison Tooke; Karen van Wyk; Fiona J White; Lucy White; Alison Woodall; Júlio César Rocha; Anita MacDonald
Journal:  Nutrients       Date:  2021-11-08       Impact factor: 5.717

7.  Health economic burden of patients with phenylketonuria (PKU) - A retrospective study of German health insurance claims data.

Authors:  Friedrich Trefz; Ania C Muntau; Kim M Schneider; Julia Altevers; Christian Jacob; Sebastian Braun; Wolfgang Greiner; Ashok Jha; Mohit Jain; Ignacio Alvarez; Paul Lane; Claudia Zeiss; Frank Rutsch
Journal:  Mol Genet Metab Rep       Date:  2021-05-13

8.  Requirements for a minimum standard of care for phenylketonuria: the patients' perspective.

Authors:  Tobias S Hagedorn; Paul van Berkel; Gregor Hammerschmidt; Markéta Lhotáková; Rosalia Pasqual Saludes
Journal:  Orphanet J Rare Dis       Date:  2013-12-17       Impact factor: 4.123

9.  Depression and anxiety among parents of phenylketonuria children.

Authors:  Mehmet Gunduz; Nur Arslan; Ozlem Unal; Sevim Cakar; Pinar Kuyum; Selda F Bulbul
Journal:  Neurosciences (Riyadh)       Date:  2015-10       Impact factor: 0.906

Review 10.  Similarities and differences in key diagnosis, treatment, and management approaches for PAH deficiency in the United States and Europe.

Authors:  Tracy Brock Lowe; Jane DeLuca; Georgianne L Arnold
Journal:  Orphanet J Rare Dis       Date:  2020-09-25       Impact factor: 4.123

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.